Bill > S1219

This bill requires healthcare providers to disclose financial incentives they receive for prescribing or dispensing certain drugs, aiming to improve transparency in public health. Specifically, it amends existing law to mandate that if a practitioner (like a doctor) is offered or receives a financial reward to switch a patient to a different, but equally effective, medication than what was originally prescribed, they must inform the patient about this incentive. Similarly, if a pharmacist is offered or receives a financial incentive to dispense a therapeutically equivalent drug instead of the one a practitioner prescribed, they must disclose this to both the prescribing practitioner and the patient. This applies to various entities, including insurance carriers, third-party administrators, and pharmacy benefits managers (PBMs), which are companies that manage prescription drug benefits on behalf of health insurers or employers.